Effectiveness of anti-B-cell maturation antigen (BCMA)-targeting therapy after selinexor treatment

被引：0
|
作者：
Baljevic, Muhamed
Moreau, Philippe
Tuchman, Sascha Alexander
Callander, Natalie Scott
Lentzsch, Suzanne
Van Domelen, Dane R.
Bentur, Ohad S.
Monge, Jorge
Biran, Noa
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[2] CHU Nantes, Hematol Dept, Nantes, France
[3] Univ N Carolina, Chapel Hill, NC USA
[4] Univ Wisconsin Hlth, Carbone Canc Ctr, Madison, WI USA
[5] Columbia Univ, Irving Med Ctr, New York, NY USA
[6] Karyopharm Therapeut Inc, Newton, MA USA
[7] Weill Cornell Med, New York, NY USA
[8] Hackensack Univ, John Theurer Canc Ctr, Med Ctr, Hackensack, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20034
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Effectiveness of anti-B-cell maturation antigen (BCMA)-targeting therapy after selinexor treatment
    Baljevic, Muhamed
    Moreau, Philippe
    Tuchman, Sascha
    Callander, Natalie
    Lentzsch, Suzanne
    Van Domelen, Dane
    Bentur, Ohad
    Monge, Jorge
    Biran, Noa
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S163 - S163
  • [2] Role of Anti-B-Cell Maturation Antigen (BCMA) in the Management of Multiple Myeloma
    Rinaldi, Ikhwan
    Muthalib, Abdul
    Edina, Brenda Cristie
    Wiyono, Lowilius
    Winston, Kevin
    [J]. CANCERS, 2022, 14 (14)
  • [3] Selinexor-based regimens in patients with multiple myeloma after prior anti-B-cell maturation antigen treatment
    Baljevic, Muhamed
    Gasparetto, Cristina
    Schiller, Gary J.
    Tuchman, Sascha A.
    Callander, Natalie S.
    Lentzsch, Suzanne
    Monge, Jorge
    Kotb, Rami
    Bahlis, Nizar J.
    White, Darrell
    Chen, Christine I.
    Sutherland, Heather J.
    Madan, Sumit
    LeBlanc, Richard
    Sebag, Michael
    Venner, Christopher P.
    Bensinger, William I.
    Biran, Noa
    DeCastro, Andrew
    Van Domelen, Dane R.
    Zhang, Chris
    Shah, Jatin J.
    Shacham, Sharon
    Kauffman, Michael G.
    Bentur, Ohad S.
    Lipe, Brea
    [J]. EJHAEM, 2022, 3 (04): : 1270 - 1276
  • [4] Selinexor-Based Regimens in Patients with Multiple Myeloma after Prior Anti-B-Cell Maturation Antigen Treatment
    Baljevic, Muhamed
    Gasparetto, Cristina
    Schiller, Gary J.
    Tuchman, Sascha A.
    Callander, Natalie S.
    Lentzsch, Suzanne
    Monge, Jorge
    Kotb, Rami
    Bahlis, Nizar J.
    White, Darrell
    Chen, Christine I.
    Sutherland, Heather J.
    Madan, Sumit
    Leblanc, Richard
    Sebag, Michael
    Venner, Christopher P.
    Bensinger, William I.
    Biran, Noa
    De Castro, Andrew
    Van Domelen, Dane R.
    Bentur, Ohad S.
    Zhang, Chris
    Shah, Jatin J.
    Shacham, Sharon
    Kauffman, Michael G.
    Lipe, Brea
    [J]. BLOOD, 2021, 138
  • [5] Secondary effects after belantamab treatment: A new anti-B-cell maturation antigen monoclonal antibody for multiple myeloma
    Paniagua, Sara Garrido
    Martinez, Pablo Prieto
    Cachon, Rafael Fores
    Carrascosa, Guiomar Bautista
    Duarte, Rafael F.
    Krsnik, Isabel
    [J]. EJHAEM, 2021, 2 (03): : 646 - 647
  • [6] Effective Targeting of Multiple B-Cell Maturation Antigen-Expressing Hematological Malignances by Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T Cells
    Friedman, Kevin M.
    Garrett, Tracy E.
    Evans, John W.
    Horton, Holly M.
    Latimer, Howard J.
    Seidel, Stacie L.
    Horvath, Christopher J.
    Morgan, Richard A.
    [J]. HUMAN GENE THERAPY, 2018, 29 (05) : 585 - 601
  • [7] Ciltacabtagene autoleucel CAR-T therapy targeting B-cell maturation antigen (BCMA) Treatment of multiple myeloma
    Lee, Sarah
    Cowan, Andrew J.
    [J]. DRUGS OF THE FUTURE, 2022, 47 (04) : 233 - 238
  • [8] Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based Immunotherapy
    Cho, Shih-Feng
    Anderson, Kenneth C.
    Tai, Yu-Tzu
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [9] The emergence of b-cell maturation antigen (BCMA) targeting immunotherapy in multiple myeloma
    Davis, James A.
    Shockley, Abigail
    Hashmi, Hamza
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (04) : 960 - 968
  • [10] Incidence and Risk Factors Associated With Bleeding Following Anti-B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)
    Mohammed, Turab
    Peres, Lauren
    Colinleitzinger, Christelle
    Puglianini, Omar Castaneda
    Oswald, Laura
    De Avila, Gabe
    Grajales-Cruz, Ariel
    Blue, Brandon
    Ochoa-Bayona, Jose
    Khimani, Farhad
    Faramand, Rawan
    Elmariah, Hany
    Lazaryan, Aleksandr
    Jain, Michael
    Liu, Hein
    Nishihori, Taiga
    Shain, Ken
    Baz, Rachid
    Alsina, Melissa
    Locke, Frederick
    Freeman, Ciara
    Hansen, Doris
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S473 - S474
12345